(Q38276267)

1 September 2017

1 reference

title

Bromodomain and extraterminal domain inhibitors (BETi) for cancer therapy: chemical modulation of chromatin structure (English)

1 reference

1 September 2017

Jun Qi

1

1 reference

1 September 2017

1 December 2014

1 reference

Cold Spring Harbor Perspectives in Biology

1 September 2017

1 reference

1 September 2017

6

1 reference

1 September 2017

12

1 reference

1 September 2017

a018663

1 reference

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

1 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292150

Small-molecule inhibition of BRDT for male contraception

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292150

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292150

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292150

Selective inhibition of BET bromodomains

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4292150

10.1101/CSHPERSPECT.A018663

6 September 2017

Identifiers

DOI

1 reference

1 September 2017

1 reference

PMC publication ID

4292150

1 September 2017

PubMed publication ID

25452384

1 reference

PMC publication ID

4292150